US Broker Ratings

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Growth with a 7.98% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) presents a compelling opportunity for investors keen on the healthcare sector, specifically within biotechnology. With a robust market capitalization of $31.6 billion, Royalty Pharma stands..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

TransMedics Group, Inc. (TMDX): Investor Outlook on a Medical Device Innovator with a 60.17% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), with a market capitalization of $2.52 billion, stands at the forefront of transforming organ transplant therapy. Known for its pioneering Organ Care System (OCS), the..

Quest Diagnostics Incorporated (DGX) Stock Analysis: A 10% Upside Potential for Investors

For investors seeking opportunities in the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing prospect. With a market capitalization of $22.48 billion, Quest Diagnostics is a leading player..

Guardant Health, Inc. (GH) Stock Analysis: Cutting-edge Diagnostics with a 7% Upside Potential

Guardant Health, Inc. (NASDAQ: GH) has emerged as a significant player in the precision oncology space, offering a suite of cutting-edge diagnostic tests that are reshaping cancer detection and research...

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 36.83% Upside in the Thriving Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED) is making waves in the healthcare sector with its innovative solutions for musculoskeletal disorders. With a market capitalization of $10.91 billion, Globus Medical stands as..

Natera, Inc. (NTRA) Stock Analysis: Evaluating a 22.62% Potential Upside in the Diagnostics Arena

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is gaining attention from the investor community thanks to its impressive revenue..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 26.85% Potential Upside in Health Information Services

For investors keen on opportunities within the healthcare sector, Doximity, Inc. (NYSE: DOCS) presents a compelling case. Headquartered in San Francisco, Doximity operates a thriving digital platform tailored for medical..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a 14.25% Upside Potential in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) stands out in the biotechnology landscape not only for its robust market presence but also for its potential upside of 14.25%. As a key player in..

Charles River Laboratories (CRL) Stock Analysis: Exploring Its 13.20% Potential Upside for Investors

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $9.03 billion,..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 17.35% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a titan in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking exposure to precision instruments and services. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with Robust Growth Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands tall in the healthcare sector, carving a niche in the specialty and generic drug manufacturing industry. As a leader in diagnostic and therapeutic solutions,..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking a Potential 114% Upside

ADMA Biologics Inc. (NASDAQ: ADMA) is emerging as a compelling opportunity within the healthcare sector, specifically in the biotechnology industry. With a market capitalization of $1.9 billion, this U.S.-based biopharmaceutical..

RadNet, Inc. (RDNT) Stock Analysis: A 58% Potential Upside Amidst Strong Buy Ratings

In the ever-evolving world of healthcare, RadNet, Inc. (NASDAQ: RDNT) stands out as a formidable player in the diagnostics and research industry. With a market cap of $4.46 billion, this..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a Potential 37.68% Upside and Analyst Consensus

Option Care Health, Inc. (NASDAQ: OPCH) operates at the intersection of healthcare innovation and patient-focused services, specializing in home and alternate site infusion therapies. With its headquarters in Bannockburn, Illinois,..

Teva Pharmaceutical Industries (TEVA): Investor Outlook Reveals 18% Potential Upside Amid Strong Buy Ratings

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector, has captured investor attention with its robust position in the drug manufacturing industry, particularly in the specialty and..

Corcept Therapeutics (CORT) Stock Analysis: Unraveling Its 6.14% Upside Potential

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach in addressing severe endocrinologic, oncologic, metabolic, and neurologic disorders...

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Potential 57% Upside Opportunity

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, is gaining the spotlight among investors due to its focus on developing therapies for rare and life-threatening diseases...

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 55% Upside Potential Beckons Investors

Investors with an eye on the biotechnology sector may want to consider Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a company at the forefront of innovative therapeutics based on ribonucleic acid interference..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds